Fig. 4.

TNFi treatment for PSO during pregnancy. (A) When TNFi treatment was stopped and who initiated treatment cessation. (B) Patient-reported reasons for stopping TNFi treatment for PSO during pregnancy. Data should be interpreted with caution due to small n numbers. (A) “Did you stop TNFi treatment and if so when?,” ^†These data do not add up to 100% as multiple answers were possible; “Whose idea was it to stop your TNFi treatment?”; (B) “Key reasons for stopping TNFi treatment” All possible answers are shown, except for the “Other” and “Physicians could not agree on the best plan” categories that recorded no answers. Multiple responses were possible. PSO, psoriasis; TNFi, tumor necrosis factor inhibitors.